Analytical Data
-
Gene name
C19orf54
- Application
-
Alternative Names
C19orf54UPF0692 Protein C19orf54
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q5BKX5
-
Expression Region
1-351aa
-
AA Sequence
MTSPCSPPLK PPISPPKTPV PQASSIPSPP LPPSPLDFSA LPSPPWSQQT PVPPPLPLPP PPAATGPAPR HVFGLEKSQL LKEAFDKAGP VPKGREDVKR LLKLHKDRFR GDLRWILFCA DLPSLIQEGP QCGLVALWMA GTLLSPPSGV PLERLIRVAT ERGYTAQGEM FSVADMGRLA QEVLGCQAKL LSGGLGGPNR DLVLQHLVTG HPLLIPYDED FNHEPCQRKG HKAHWAVSAG VLLGVRAVPS LGYTEDPELP GLFHPVLGTP CQPPSLPEEG SPGAVYLLSK QGKSWHYQLW DYDQVRESNL QLTDFSPSRA TDGRVYVVPV GGVRAGLCGQ ALLLTPQDCS H
-
Molecular Weight
37.7 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C19orf54, also known as "chromosome 19 open reading frame 54," is a relatively newly identified protein with potential implications in various biological processes. Research into C19orf54 has gained traction due to its involvement in cellular functions such as proliferation, differentiation, and apoptosis. Despite its potential significance, the exact biological role and mechanisms underlying the function of C19orf54 remain largely unexplored. Preliminary studies suggest that it may play a critical role in certain diseases, including cancers, where its expression levels may correlate with tumor progression and patient prognosis. Additionally, its localization within cells and potential interactions with other proteins present intriguing avenues for further investigation. The development of recombinant C19orf54 protein has become essential for elucidating these pathways, enabling researchers to conduct functional assays, structural studies, and ultimately explore its therapeutic potential. As the landscape of proteomics continues to expand, the recombinant production of C19orf54 may also facilitate high-throughput screening efforts and further our understanding of its role in health and disease. Consequently, the comprehensive study of this protein could not only enrich our fundamental knowledge of cellular biology but also pave the way for novel diagnostic and therapeutic strategies targeting diseases associated with dysregulated C19orf54 expression.
